Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China · Delayed Price · Currency is CNY 5.40
-0.22 (-3.91%)
At close: Sep 9, 2026
SHA:688373 Market Cap
SHA:688373 has a market cap or net worth of 3.54 billion as of September 9, 2026. Its market cap has decreased by -33.60% in one year.
Market Cap
3.54B
Enterprise Value
3.39B
Revenue
164.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.40
ChartMarket Cap Chart
Since August 5, 2022, SHA:688373's market cap has decreased from 7.13B to 3.54B, a decrease of -50.29%. That is a compound annual growth rate of -15.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 3.54B | -10.51% |
| Dec 31, 2025 | 3.96B | 22.34% |
| Dec 31, 2024 | 3.24B | -24.35% |
| Dec 29, 2023 | 4.28B | -26.30% |
| Dec 30, 2022 | 5.81B | -18.57% |
| Aug 5, 2022 | 7.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanjing Hicin Pharmaceutical | 3.76B |
| Lionco Pharmaceutical Group | 3.72B |
| Zhuhai Rundu Pharmaceutical | 3.72B |
| Hainan Shuangcheng Pharmaceuticals | 3.70B |
| Shandong Sinobioway Biomedicine | 3.57B |
| Guangdong Lifestrong Pharmacy | 3.51B |
| Nanjing Well Pharmaceutical Group | 3.45B |
| Tibet AIM Pharm. | 3.43B |